Skip to content

Lidocaine Infusion for Pain After Herniotomy

Lidocaine Infusion for Pain After Herniotomy (LIPAH), A Randomized Placebo-controlled Trial (LIPAH Trial)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03673163
Acronym
LIPAH
Enrollment
180
Registered
2018-09-17
Start date
2018-11-06
Completion date
2019-06-30
Last updated
2018-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Hernia, Inguinal, Lidocaine, Pain, Postoperative

Keywords

chronic postoperative pain, lidocaine infusion, inguinal herniotomy

Brief summary

This study seeks to investigate lidocaine infusion to reduce occurrence of chronic postoperative pain at 3-month after inguinal herniotomy

Detailed description

Inguinal hernia repair is associated with a 5%-30% incidence of chronic pain; however, the pathogenesis remains unknown, and few studies have assessed chronic pain as the primary aim of the study. Lidocaine infusion could be a possible approach to reducing the prevalence of chronic pain after herniotomy. Recently, a meta-analysis concluded a modest but statistically significant reduction of pain severity in the first four postoperative hours measured by the visual analogue scale (mean difference, -0.84; 95% CI, -1.10 to -0.59). However, a more recent meta-analysis found that only limited clinical data and biological plausibility support lidocaine infusions for the prevention of postoperative persistent pain (odds ratio, 0.29; 95% CI, 0.18 to 0.48). This study was designed to investigate whether lidocaine infusion after inguinal herniotomy would lower the incidence of chronic postoperative pain.

Interventions

DRUGLidocaine

Infusion of 2% lidocaine hydrochloride at 4 mL/h,prior to surgery and discontinued until 24 h after surgery.

DRUGControl

Infusion of normal saline at 4 mL/h, prior to surgery and discontinued until 24 h after surgery.

Sponsors

Guangzhou First People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo unilateral inguino herniotomy

Exclusion criteria

* (1)ASA classification status III or above * (2)Body weight\<35kg * (3)Liver cirrhosis * (4)A history of previous herniotomy * (5)Pregnancy * (6)Severe arrhythmia * (7)Congestive heart failure * (8)Opioid or steroid use 6 months before surgery * (9)Allergy to lidocaine * (10)Chronic pain syndrome (any type) * (11)Emergency surgery * (12)Incapacity to give an informed consent, Visual dysfunction or severe mental disorders

Design outcomes

Primary

MeasureTime frameDescription
Occurrence of chronic painAt 3 months after surgery.Chronic pain was assessed in accordance with the IMMPACT recommends in the domains of: (1) absence or presence of pain in the area of the surgery, (2) clinically important (NRS ≥ 4 on a 0- to 10-point scale) daily average pain, (3) clinically important pain at rest, (4) clinically important pain intensity upon movement or activity, (5) pain qualities, and (6) physical and emotional functioning.

Secondary

MeasureTime frameDescription
FatigueUp to 48 hours after surgeryUse an 0- to 10-point Numeric Rating Scale to asses
SedationUp to 48 hours after surgeryUse an 0- to 10-point Numeric Rating Scale to asses
Postoperative nausea and vomiting (PONV)Up to 48 hours after surgeryUse an 0- to 10-point Numeric Rating Scale to asses
Chronic pain at 6-month after surgeryAt 6 months after surgery.Chronic pain was assessed in accordance with the IMMPACT recommends in the domains of: (1) absence or presence of pain in the area of the surgery, (2) clinically important (NRS ≥ 4 on a 0- to 10-point scale) daily average pain, (3) clinically important pain at rest, (4) clinically important pain intensity upon movement or activity, (5) pain qualities, and (6) physical and emotional functioning.
Chronic pain at 12-month after surgeryAt 12 months after surgery.Chronic pain was assessed in accordance with the IMMPACT recommends in the domains of: (1) absence or presence of pain in the area of the surgery, (2) clinically important (NRS ≥ 4 on a 0- to 10-point scale) daily average pain, (3) clinically important pain at rest, (4) clinically important pain intensity upon movement or activity, (5) pain qualities, and (6) physical and emotional functioning.
Postoperative acute painUp to 48 hours after surgeryUse an 11-point Numeric Rating Scale (NRS) to assess the postoperative acute pain

Countries

China

Contacts

Primary ContactXiangcai Ruan, PhD
xc_ruan@hotmail.com+8620-81048306
Backup ContactDanyang Pan, MD
Pandy0505@163.com+86-13246886285

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026